Biotech · Private company · Tucson, AZ, US
Precision Epigenomics, Inc.
Track this companyFree. Adds Precision Epigenomics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Development of a Molecular Assay to Diagnose Malignant Pleural EffusionsFiscal year 2025 · $70KNIH RePORTER 3R44CA287829-01A1S1 · fetched Nov 12, 2026
- Development of a Molecular Assay to Diagnose Malignant Pleural EffusionsFiscal year 2025 · $1MNIH RePORTER 5R44CA287829-02 · fetched Nov 12, 2026
- Development of a Molecular Assay to Diagnose Malignant Pleural EffusionsFiscal year 2024 · $1MNIH RePORTER 1R44CA287829-01A1 · fetched Nov 12, 2026